Skip to main content

Table 1 Characteristics of the study population

From: Socio-economic drivers of drug-resistant tuberculosis in Africa: a scoping review

Characteristics

N

%

Citation

Mean age

33, 7

–

[19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37]

Sex

 Male

276,751

66,9

[19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36, 38,39,40]

 Female

137,025

33,1

[19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36, 38,39,40]

Type of DR TB

 RR/ MDR

2173

0,5

[19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35, 38, 39]

 PRE- XDR

104

0, 03

[19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35, 38, 39]

 XDR

330

0,08

[19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35, 38, 39]

Mono drug resistance (other than RIF)

136

0,03

[19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35, 38, 39]

Poli drug resistance)

18

0,004

[19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35, 38, 39]

STB/ controls

2473

0,5

[19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35, 38, 39]

DRTB type not indicated (no breakdown)

408,542

98,7

[36, 37, 40]

Duration of study – Average duration of studies

32 months

–

[19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40]

Treatment outcomes

 Favourable (Cured/ Treatment completed)

89,410

21,60

[29, 31, 33, 37]

 Unfavourable (Died/ Defaulted/ LTFU/ Failed/ relapse)

66,063

15, 96

[29, 31, 33, 37]

 Transferred out

8

0,002

[31]

 Treatment outcome not evaluated in study

258,295

62,42

[30, 32, 34,35,36, 38,39,40]